Anticholinergic medication burden - asociated cognitive impairment in schizophrenia / Yash B. Joshi en The American Journal of Psychiatry, Año 2021 - Vol. 178 - No.9 (Septiembre)

Público ISBD [artículo]  inThe American Journal of Psychiatry > Año 2021 - Vol. 178 - No.9 (Septiembre) . - pp. 838-847 Título : Anticholinergic medication burden - asociated cognitive impairment in schizophrenia Tipo de documento: texto impreso Autores: Yash B. Joshi, Autor ; Michael L. Thomas, Autor ; David L. Braff, Autor Fecha de publicación: 2021 Artículo en la página: pp. 838-847 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Espectro de la esquizofrenia, Trastornos psicóticos, Psicofarmacología, Anticolinérgicos, Cognición - Aprendizaje - Memoria Resumen: Many psychotropic medications used to treat schizophrenia have significant anticholinergic properties, which are linked to cognitive impairment and dementia risk in healthy subjects. Clarifying the impact of cognitive impairment attributable to anticholinergic medication burden may help optimize cognitive outcomes in schizophrenia. The aim of this study was to comprehensively characterize how this burden affects functioning across multiple cognitive domains in schizophrenia outpatients. Link: ./index.php?lvl=notice_display&id=27335 [artículo] Anticholinergic medication burden - asociated cognitive impairment in schizophrenia [texto impreso] / Yash B. Joshi, Autor ; Michael L. Thomas, Autor ; David L. Braff, Autor . - 2021 . - pp. 838-847. Idioma : Inglés (eng) Idioma original : Inglés (eng) in The American Journal of Psychiatry > Año 2021 - Vol. 178 - No.9 (Septiembre) . - pp. 838-847 Palabras clave: Espectro de la esquizofrenia, Trastornos psicóticos, Psicofarmacología, Anticolinérgicos, Cognición - Aprendizaje - Memoria Resumen: Many psychotropic medications used to treat schizophrenia have significant anticholinergic properties, which are linked to cognitive impairment and dementia risk in healthy subjects. Clarifying the impact of cognitive impairment attributable to anticholinergic medication burden may help optimize cognitive outcomes in schizophrenia. The aim of this study was to comprehensively characterize how this burden affects functioning across multiple cognitive domains in schizophrenia outpatients. Link: ./index.php?lvl=notice_display&id=27335

---

1 (1 - 1 / 1)